INTRODUCTION
Cervical cancer is the second most common cancer among women in the developing countries and the seventh most common cancer in the developed countries. 1 Over 500000 new cases are seen yearly 1 with over 80% of them being from the developing countries. [1] [2] [3] Worldwide, it claims the lives of 300,000 women annually with over 80% coming from the developing countries. 1 It is the most common gynecological cancer and a leading cause of cancer death in women in Nigeria.
HPV infection. 7 Several studies in Nigeria have demonstrated an association between cervical cancer and C. trachomatis infection 7, [8] [9] [10] [11] [12] [13] [14] as it may possibly be one of the co-factors that promote the oncogenic potential of the HPV. [15] [16] [17] Chlamydia trachomatis, an obligate intracellular Gram negative bacterium, is one of the most common sexually transmitted disease agents. Its worldwide prevalence is 20-40% [18] [19] [20] with several studies in Nigeria showing equally high prevalence among the women in the reproductive age group 8, 10 antenatal women 9, 11 and individual with sexually transmitted infection in Nigeria. 8, [12] [13] [14] Koutsky et al. 6 found that Cervical Intraepithelial Neoplasia (CIN), after adjustment for HPV status, was independently associated with serological evidence of chlamydial infection.
Infection with C. trachomatis is invariably accompanied by formation of reactive oxygen and nitrogen species that can damage DNA, proteins and cell membranes. 21, 22 Inflammation induces increasing cell damage, cell death and compensatory cell proliferation. This process and its influence may lead to mutagenesis. 23, 24 DNA damage caused by oxidative stress resulting from Chlamydia infection, 25 may be one mechanism for Chlamydiainduced carcinogenesis. Chlamydia trachomatis also has an anti-apoptotic activity. 26 The infection causes inflammation, necrosis, scarring and cervical hypertrophy. It has also been speculated that the immune system cells that are activated at Chlamydia infection sites may damage normal cells.
A search of the literature showed no published data on the association between C. trachomatis and cervical cancer or cervical intra-epithelial lesion in Nigeria. This study is therefore aimed to determine the prevalence of C. trachomatis and the association between Chlamydia trachomatis infection and cervical intra-epithelial lesion.
METHODS
The study is a cross-sectional case control study carried out at the cytology clinic, colposcopy clinic and gynaecology clinic of the Lagos University teaching hospital.
The sample size for the study was calculated using the statistical formula by Schlesselman. 27 The study participants were then selected by consecutive sampling method from the three clinics and were divided into two groups:
The case group consists of 30 women with abnormal smears seen in all the clinics and referred to the colposcopy clinic, and the control group consists of 60 women with normal Pap smear seen in the cytology clinic.
Both groups of women were offered a group health talk on cervical cancer and chlamydial infection on presentation at the cytology and colposcopy clinics. Eligible participants at the various clinics were also given information leaflets and counseled appropriately on the objectives of the study. Excluded from the study were women who were pregnant, those who have had hysterectomy done, and pre-pubertal and adolescent girls who were attending the gynaecology clinic.
For the purpose of this study, abnormal Pap smear was defined using the Bethesda classification 28 as Atypical Squamous Cells of Undetermined Significance (ASCUS), Low grade Squamous Intraepithelial Lesion (LSIL), High grade Squamous Intraepithelial Lesion (HSIL), Atypical Squamous Cells High Grade (ASC-H) cannot be excluded and Atypical Glandular Cells of Undetermined Significance (AGCUS).
Information on the socio-demographics, sexual and reproductive variables were obtained using a structured interviewer-administered questionnaire. This was then followed by a sterile speculum examination and endocervical swab was collected. Women attending the cytology clinic had both Pap smear (for precancerous lesion) and endocervical swab (for Chlamydia trachomatis antigen detection test). Women who were referred to the colposcopy clinic with a positive Pap smear had only endocervical swab done for Chlamydia trachomatis antigen detection test using PCR.
The swab sample was transported in a cold-chain box to the central research laboratory of the college of medicine for analysis by Polymerase Chain Reaction (PCR) test using consensus primers targeting the Major Outer Membrane Proteins (MOMP) and plasmid of the Chlamydia trachomatis.
All quantitative data were entered in the computer and analyzed using Epi-Info statistical package (version 3.4.3). Descriptive statistics were then computed for all relevant data. The association between C. trachomatis and intraepithelial lesion was tested using chi-square to determine the difference. All significance were reported at P <0.05.
Ethical clearance for the study was obtained from the hospital's health research and ethics committee and written consent obtained from each participant prior to involvement in the study. Table 1 , a total of 90 women (30 cases and 60 controls) participated in the study. Data were completed for analysis in all of them. The age range for the cases was 25-56 years with a mean age of 37.5 ± 5.6 years. The age range for control was 29-71 years with a mean age of 41.8 ± 8.5 years. There is no statistically significant difference in mean ages of the case and control groups (P = 0.06). There were also no statistically significant differences in the parity, age at sexual debut, age at marriage and age at delivery between the case and control groups (P >0.05) ( Table 1 and 2). Mean age at first delivery (Mean ± SD) 22.7 ± 7.1 24.0 ± 4.7
RESULTS

As shown in
The overall prevalence of C. trachomatis among the 90 participants in this study using the PCR technique was 27.7% ( Table 4 showed that 50% of the cases (abnormal smear) were positive for C. trachomatis, whereas, only 16.7% of the controls (normal smear) were positive for C. trachomatis and this difference was statistically significant (X 2 = 10.95; P = 0.001). Table 5 showed no statistically significant association between age of the participants and prevalence of C. trachomatis among women with abnormal smear (P = 0.935). It was also shown that the prevalence of C. trachomatis was 61.5% in women with HISL, 50% in women with LSIL, 40% in women with ASC-H and 25.0% in women with ASCUS. However, there was no statistically significant association between prevalence of C. trachomatis and cervical cytological types (X 2 = 1.892; P = 0.595).
DISCUSSION
Infection by Chlamydia trachomatis has been recognized as an important public health problem. 29 The WHO estimates that approximately 50 million cases of Chlamydia trachomatis infection occur per year worldwide. 30 It causes a widespread spectrum of diseases including uterine-cervical lesions. 31 The prevalence of C. trachomatis in the general population in Nigeria showed ranges between 6.5% and 66.8%, [8] [9] [10] [11] [12] [13] [14] depending on the ages, groups and localities of the surveyed population. In our study, the prevalence was 27.7% which is within the quoted range in the previous studies.
The C. trachomatis infection is noted among people in the reproductive age group in this study (25-45 years) with a decreasing trend noted with age as earlier reported in various studies on Chlamydia. 29, 32 This is probably due to the decreased frequency of sexual activity with age thus leading to a reduction in the prevalence in the older age group.
The role of Chlamydia trachomatis in the pathogenesis of CIN remains unexplained and sometimes controversial; while some studies show no significant association between C. trachomatis and cytologically or histologically diagnosed precancerous lesion of the cervix, 33, 34 others have shown a significant association. 35, 36 In this study, a higher prevalence of C. trachomatis (50%) was reported among women with abnormal smear compared to women with normal cytology (16.7%) and this difference was statistically significant (OR = 10.95; P = 0.001). This finding is in agreement with a study done in Argentina 35 where a prevalence of 47% and 11% was reported in the case and control groups respectively. A similar study done in Brazil 36 also showed a significantly high prevalence of C. trachomatis among women with histologically diagnosed precancerous lesion of the cervix. However, a study in Slovenia 33 and Netherlands 34 did not find any significant association. The similarities observed in our study and that of the Argentina and Brazil studies may be due to the relatively high prevalence of sexually transmitted infection often reported in developing countries as opposed to the developed countries.
37,38
Limitations of the study This is a preliminary study to find out the association between Chlamydia trachomatis and precancerous lesions of the cervix using molecular biology diagnostic techniques. It would have been interesting to detect specific serotype of C. trachomatis present in precancerous lesion of the cervix; however, subtyping of Chlamydia trachomatis involves sequencing that requires special facilities (Sequencer and reagents) which are expensive and not readily available in Nigeria. The other limitations of the study were due to cost and time constraints. Selection of women with abnormal smears would have been best done histologically using colposcopy directed biopsy but for the high cost implication and also it would have been interesting to treat the identified Chlamydia cases with antibiotics and repeat the test after about six months to determine the effect of clearance of Chlamydia trachomatis infection in the study population. A larger study with grant should probably look at this aspect.
CONCLUSION
This study showed an association between Chlamydia trachomatis, a Sexually Transmitted Infection (STI), and precancerous lesions of the cervix among women in Lagos, Nigeria. This will thus necessitate a need for proper and more aggressive treatment of C. trachomatis in women diagnosed with STI. The routine screening and treatment of sexually active adolescents and women in the reproductive age group is also recommended as an indirect measure to reducing the incidence of cervical cancer in Nigeria. A larger and more robust study should however, be done in the future to properly evaluate the effect of treatment of C. trachomatis on cervical cytology.
